Your browser doesn't support javascript.
loading
Siponimod: Disentangling disability and relapses in secondary progressive multiple sclerosis.
Cree, Bruce Ac; Magnusson, Baldur; Rouyrre, Nicolas; Fox, Robert J; Giovannoni, Gavin; Vermersch, Patrick; Bar-Or, Amit; Gold, Ralf; Piani Meier, Daniela; Karlsson, Göril; Tomic, Davorka; Wolf, Christian; Dahlke, Frank; Kappos, Ludwig.
Affiliation
  • Cree BA; Department of Neurology, UCSF Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA.
  • Magnusson B; Novartis Pharma AG, Basel, Switzerland.
  • Rouyrre N; Novartis Pharma AG, Basel, Switzerland.
  • Fox RJ; Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Giovannoni G; Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Vermersch P; University of Lille, CHU Lille, LIRIC-INSERM U995, Lille, France.
  • Bar-Or A; Center for Neuroinflammation and Experimental Therapeutics and Multiple Sclerosis Division, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA/Neuroimmunology Unit, Montreal Neurological Institute and Hospital, McGill University, Montreal, QC, Can
  • Gold R; Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany.
  • Piani Meier D; Novartis Pharma AG, Basel, Switzerland.
  • Karlsson G; Novartis Pharma AG, Basel, Switzerland.
  • Tomic D; Novartis Pharma AG, Basel, Switzerland.
  • Wolf C; Lycalis sprl, Brussels, Belgium.
  • Dahlke F; Novartis Pharma AG, Basel, Switzerland.
  • Kappos L; Neurologic Clinic and Policlinic, Departments of Medicine, Clinical Research, Biomedicine and Biomedical Engineering, University Hospital, University of Basel, Basel, Switzerland.
Mult Scler ; 27(10): 1564-1576, 2021 09.
Article in En | MEDLINE | ID: mdl-33205682

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Azetidines / Benzyl Compounds / Multiple Sclerosis, Chronic Progressive Type of study: Clinical_trials Limits: Humans Language: En Journal: Mult Scler Journal subject: NEUROLOGIA Year: 2021 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Azetidines / Benzyl Compounds / Multiple Sclerosis, Chronic Progressive Type of study: Clinical_trials Limits: Humans Language: En Journal: Mult Scler Journal subject: NEUROLOGIA Year: 2021 Type: Article Affiliation country: United States